Here’s Why Viking Therapeutics Rose Over 50% On Obesity Drug Data

best Performing Small-cap Stocks in Feb 2023 Worst Performing Small-cap Stocks in Feb 2023 Keywords Studios Purple Innovation Top 10 Holdings Of Cathie Wood

Viking Therapeutics reports positive Phase 1 data on its obesity candidate VK2735. During the study, participants lost up to 7.9% of their body weight from their baseline. Phase 2 is planned for mid-2023 Viking has five more novel compounds in various stages of clinical trials, which can move the needle on share prices. 5 stocks […]

result macau

togel online

casino terpercaya